CSL Behring is a global leader in the plasma protein biotherapies industry. We research, develop, manufacture and market biotherapies, which are used to treat serious and rare conditions.

 Users of our therapies rely on them to help improve their quality of life and, in many cases, for life itself. Our commitment to helping to improve the quality of life for those who use our therapies is evident in everything we do